Beta-blockers significantly reduce exacerbations in COPD patients regardless of the severity of their airflow obstruction and appear to be safe, data from the COPDGene study suggests. Analysis of 3,464 patients in the study, just published in Thorax, found 474 (14%) were taking beta-blockers. During two years of follow-up beta-blocker use was associated with a 27% ...
Already a member?
Enter your email to keep reading.